文献速递神经核医学放射性药物与辐射防护

探究阿尔茨海默病研究中Tau与淀粉样蛋白示踪剂的颅骨结合

Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease.
PubMed 文献 · J Nucl Med · 2022-08-11

在313名认知正常或轻度受损参与者中,用CT定义颅骨掩模量化[18F]flortaucipir(FTP)颅骨摄取,并评估[18F]florbetapir与[11C]Pittsburgh compound B的颅骨摄取。约16%的FTP扫描颅骨信号高,多为女性,且女性颅骨密度越低FTP颅骨信号越高;颅骨摄取在纵向扫描和不同示踪剂间稳定,在淀粉样蛋白阴性个体中影响颞叶定量估计。

要点

  • 313例中50例(约16%)FTP扫描颅骨信号高,其中女性41例(82%)。
  • 女性颅骨密度越低,FTP颅骨信号越高;仅21%高颅骨结合女性诊断为骨质增生。
  • 颅骨摄取在纵向FTP扫描及不同示踪剂间稳定,淀粉样蛋白阴性者颞叶定量受影响。

核心结论

  • FTP颅骨结合是稳定的、参与者特异性现象,与已知脱靶区域无关。
  • 效应主要见于女性,部分与较低骨密度相关。
  • [11C]Pittsburgh compound B颅骨结合的存在提示脱氟不能完全解释FTP颅骨信号。
  • 颅骨信号可影响定量分析且存在性别差异,在衰老与阿尔茨海默病研究中应明确处理。

研究设计与样本

  • 在313名认知正常和轻度受损参与者中,用CT扫描定义颅骨掩模以量化FTP颅骨摄取。
  • 同时评估淀粉样β PET示踪剂[18F]florbetapir和[11C]Pittsburgh compound B的颅骨摄取(n=152)。
  • 用高斯混合模型为每种示踪剂定义颅骨结合的异常水平。

主要发现

  • 313例FTP扫描中50例(约16%)颅骨信号高,其中女性41例(82%)。
  • 女性中颅骨密度越低与FTP颅骨信号越高相关。
  • 神经放射科医生视觉判读显示与骨质增生显著相关,但高颅骨结合女性中仅21%诊断为骨质增生。
  • FTP颅骨信号与其他已知脱靶区域(基底节和脉络丛)无实质相关。
  • 颅骨摄取在纵向FTP扫描间及不同示踪剂间一致;在淀粉样β阴性而非阳性个体中,FTP颅骨结合影响颞叶区域定量估计。

关键数值与推荐

  • 313例中50例(约16%)FTP扫描颅骨信号高。
  • 高颅骨信号者中女性41例(82%)。
  • 高颅骨结合女性中仅21%诊断为骨质增生。
  • 淀粉样β示踪剂颅骨摄取评估样本n=152。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Off-target binding of [18F]flortaucipir (FTP) can complicate quantitative PET analyses. An underdiscussed off-target region is the skull. Here, we characterize how often FTP skull binding occurs, its influence on estimates of Alzheimer disease pathology, its potential drivers, and whether skull uptake is a stable feature across time and tracers. Methods: In 313 cognitively normal and mildly impaired participants, CT scans were used to define a skull mask. This mask was used to quantify FTP skull uptake. Skull uptake of the amyloid-β PET tracers [18F]florbetapir and [11C]Pittsburgh compound B (n = 152) was also assessed. Gaussian mixture modeling defined abnormal levels of skull binding for each tracer. We examined the relationship of continuous bone uptake to known off-target binding in the basal ganglia and choroid plexus as well as skull density measured from the CT. Finally, we examined the confounding effect of skull binding on pathologic quantification. Results: We found that 50 of 313 (∼16%) FTP scans had high levels of skull signal. Most were female (n = 41, 82%), and in women, lower skull density was related to higher FTP skull signal. Visual reads by a neuroradiologist revealed a significant relationship with hyperostosis; however, only 21% of women with high skull binding were diagnosed with hyperostosis. FTP skull signal did not substantially correlate with other known off-target regions. Skull uptake was consistent over longitudinal FTP scans and across tracers. In amyloid-β-negative, but not -positive, individuals, FTP skull binding impacted quantitative estimates in temporal regions. Conclusion: FTP skull binding is a stable, participant-specific phenomenon and is unrelated to known off-target regions. Effects were found primarily in women and were partially related to lower bone density. The presence of [11C]Pittsburgh compound B skull binding suggests that defluorination does not fully explain FTP skull signal. As signal in skull bone can impact quantitative analyses and differs across sex, it should be explicitly addressed in studies of aging and Alzheimer disease.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Flores S, Chen CD, Su Y, et al. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease. J Nucl Med. 2022. PMID: 35953305. doi:10.2967/jnumed.122.263948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。